{"id":"NCT02876835","sponsor":"GlaxoSmithKline","briefTitle":"Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)","officialTitle":"A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-27","primaryCompletion":"2021-04-19","completion":"2021-04-19","firstPosted":"2016-08-24","resultsPosted":"2022-04-14","lastUpdate":"2024-04-02"},"enrollment":3872,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anaemia"],"interventions":[{"type":"DRUG","name":"Daprodustat","otherNames":[]},{"type":"DRUG","name":"Darbepoetin alfa","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Iron Therapy","otherNames":[]}],"arms":[{"label":"Daprodustat","type":"EXPERIMENTAL"},{"label":"Darbepoetin alfa","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.","primaryOutcome":{"measure":"Time to First Occurrence of Adjudicated Major Adverse Cardiovascular Event (MACE) During Cardiovascular (CV) Events Follow-up Time Period (Non-inferiority Analysis)","timeFrame":"Up to 4.3 person-years for CV follow-up time period","effectByArm":[{"arm":"Daprodustat","deltaMin":10.86,"sd":null},{"arm":"Darbepoetin Alfa","deltaMin":10.63,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":22},"locations":{"siteCount":574,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","Colombia","Czechia","Denmark","Estonia","France","Germany","Greece","Hong Kong","Hungary","India","Israel","Italy","Malaysia","Mexico","Netherlands","New Zealand","Philippines","Poland","Portugal","Romania","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom","Vietnam"]},"refs":{"pmids":["34865143","38383961","36565721","36005278","34739196"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":63,"n":3872},"commonTop":["Hypertension","Oedema peripheral","Urinary tract infection","Diarrhoea","Nasopharyngitis"]}}